ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,180Medicare Part D Prescriptions Filled, Including Refills

Rank: 7 out of 277

$982K Total Retail Price of All Prescriptions

Rank: 13 out of 277

580 Patients Receiving at Least One Drug in Part D
67%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 580 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

6% of this provider’s 580 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

2% of this provider’s 9,956 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 56%.

Prescription Price

$69 was the average price of a prescription from this provider, compared to $137 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
AMLODIPINE BESYLATE 544 404 1 7
METOPROLOL TARTRATE 423 380 2 13
OMEPRAZOLE 388 267 3 9
SIMVASTATIN 377 259 4 5
CLOPIDOGREL 351 266 5 26
FUROSEMIDE 318 238 6 8
LEVOFLOXACIN 291 176 7 36
WARFARIN SODIUM 259 198 8 18
METFORMIN HCL 256 184 9 15
PLAVIX 230 172 10 38
ZOLPIDEM TARTRATE 217 116 11 16
PREDNISONE 215 126 12 4
TRAMADOL HCL 214 136 13 34
DONEPEZIL HCL 201 187 14 32
OXYCODONE-ACETAMINOPHEN 194 149 S2 15 37
ATORVASTATIN CALCIUM 184 127 16 14
PANTOPRAZOLE SODIUM 161 124 17 43
DIGOXIN 158 107 18 53
DIOVAN HCT 147 127 19 40
METOPROLOL SUCCINATE 134 100 20 23
CELEBREX 130 113 21 83
LISINOPRIL 130 114 21 20
RAMIPRIL 121 76 23 60
IBUPROFEN 121 70 23 78
ADVAIR DISKUS 118 56 25 2
CARVEDILOL 117 82 26 28
LIDODERM 114 91 27 49
SANTYL 112 100 28 86
IPRATROPIUM-ALBUTEROL 110 103 29 62
AMLODIPINE BESYLATE-BENAZEPRIL 110 76 29 61
LACTULOSE 110 90 29 67
HYDROCHLOROTHIAZIDE 109 102 32 30
LEVOTHYROXINE SODIUM 103 68 33 11
LEVETIRACETAM 101 77 34 112
CLOTRIMAZOLE-BETAMETHASONE 101 51 34 72
POTASSIUM CHLORIDE 100 64 36 31
LANTUS 98 64 37 57
DIOVAN 98 95 37 24
NIFEDIPINE ER 95 75 39 135
RISPERIDONE 88 58 40 69
NEXIUM 88 76 40 21
GLIMEPIRIDE 87 81 42 41
SINGULAIR 87 39 42 6
LOSARTAN-HYDROCHLOROTHIAZIDE 86 81 44 74
ESCITALOPRAM OXALATE 85 77 45 59
LEVEMIR 80 36 46 176
ENALAPRIL MALEATE 79 72 47 29
METOCLOPRAMIDE HCL 79 64 47 115
LYRICA 79 38 47 93
HYDRALAZINE HCL 78 60 50 120
NAMENDA 75 63 51 51
NAPROXEN 75 59 51 81
PROAIR HFA 75 35 51 3
FAMOTIDINE 74 61 54 33
MUPIROCIN 71 57 55 88
TORSEMIDE 70 34 56 220
SERTRALINE HCL 68 55 57 48
CLONIDINE HCL 68 14 57 58
GABAPENTIN 67 47 59 44
ACETAMINOPHEN-CODEINE 65 48 S3 60 134
METOLAZONE 64 41 61 160
GLYBURIDE-METFORMIN HCL 63 31 R 62 125
FENTANYL 62 55 S2 63 96
ENDOCET 61 27 S2 64 55
ISOSORBIDE MONONITRATE ER 59 38 65 68
GLIPIZIDE 57 47 66 77
NIFEDICAL XL 57 49 66 239
SPIRONOLACTONE 55 31 68 114
NOVOLOG 55 41 68 98
CYCLOBENZAPRINE HCL 55 18 R 68 92
PROCRIT 55 37 68 148
AZITHROMYCIN 54 34 72 12
MELOXICAM 54 48 72 56
HYDROMORPHONE HCL 54 35 S2 72 245
HUMALOG 53 31 75 247
JANUVIA 53 33 75 50
ALLOPURINOL 52 49 77 75
PHENYTOIN SODIUM EXTENDED 51 17 78 147
FLUTICASONE PROPIONATE 51 15 78 19
NATEGLINIDE 50 35 80 157
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.